HPV状态对远处转移口咽癌生存的影响
本研究基于美国国家癌症数据库分析768例远处转移口咽鳞癌患者,比较HPV阳性与阴性者的生存差异。结果显示HPV阳性患者1年及2年生存率分别为67%和42%,高于阴性者的49%和27%,且HPV阳性与治疗和非治疗患者的中位生存改善相关。
要点
- 远处转移口咽癌中HPV阳性者生存优于HPV阴性者。
- HPV阳性患者1年及2年生存率分别为67%和42%。
- HPV阳性与治疗和非治疗患者的中位生存改善相关。
核心结论
- 远处转移口咽鳞癌中,HPV阳性者的生存优于HPV阴性者,且对治疗反应性更高。
研究设计与样本
- 回顾性队列研究,查询美国国家癌症数据库,纳入768例有HPV和生存数据的远处转移口咽鳞癌病例。
主要发现
- HPV阴性者1年和2年生存率分别为49%和27%,HPV阳性者分别为67%和42%。
- HPV阳性与治疗及未治疗患者的中位生存改善相关。
- 多因素分析中,年龄、合并症和HPV状态为生存改善的预测因素。
临床怎么用
- 对于远处转移口咽鳞癌患者,HPV状态可用于生存风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human papillomavirus (HPV)-positive oropharynx squamous cell carcinoma (OPSCC) is known to have improved survival over HPV-negative disease. However, it is largely unknown whether HPV status similarly affects survival in patients presenting with distant metastatic disease. We queried the National Cancer Database for OPSCC with distant metastasis. Kaplan-Meier curves and Cox proportional hazards regression models controlling for relevant demographics were used to evaluate overall survival. In total, 768 OPSCC cases were available for analysis with HPV and survival data: 50% of cases were HPV negative and 50% were HPV positive. The 1- and 2-year survival for HPV-negative disease was 49% and 27%, respectively, as compared with 67% and 42% in the HPV-positive cohort. HPV positivity was associated with improved median survival in treated and untreated patients. Age, comorbidities, and HPV status were predictive of improved survival on multivariate analysis. HPV-positive OPSCC has improved survival in the setting of distant metastatic presentation as compared with HPV-negative disease and shows greater responsiveness to treatment.
引用
- Kaplon AW, Galloway TJ, Bhayani MK, et al. Effect of HPV Status on Survival of Oropharynx Cancer with Distant Metastasis. Otolaryngol Head Neck Surg. 2020. PMID: 32204640. doi:10.1177/0194599820913604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。